Welcome Stockaholics!

We are a new and fast growing financial forum! Sign up for free and let's talk stocks!

  1. Do you want to help develop this community? We are looking for contributions from investors and traders like you! What stocks do you follow? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing financial forum!
    Dismiss Notice
  2. You will notice a live chat widget on the right. Click in to join us and lets hear about how you nailed that last UWTI trade!
    Dismiss Notice

DVAX - Dynavax Technologies Corporation

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by StockJock-e, Sep 6, 2016.

  1. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,213
    Likes Received:
    1,085
    Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the United States. Its development programs focuses on vaccine adjuvants, cancer immunotherapy, and autoimmune and inflammatory diseases. The company's lead products include HEPLISAV-B, an investigational adult hepatitis B vaccine, which is in Phase III clinical trials; and SD-101, a C Class CpG TLR9 agonist for the treatment of cancer, which is in Phase I/II multicenter clinical trial. Its product portfolio also comprises AZD1419 for the treatment of asthma, which is in Phase II clinical trial; DV1179, a TLR7/9 inhibitor that is in Phase Ib/IIa for the treatment of autoimmune and inflammatory conditions; and DV281 and CpG-Nanoparticles, which are in preclinical studies for cancer immunotherapy. It has a research collaboration and license agreement with AstraZeneca AB to conduct a Phase IIa safety and efficacy trial of AZD1419 for the treatment of asthma; and strategic alliance with GlaxoSmithKline to discover, develop, and commercialize TLR inhibitors. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.

    [​IMG]
     
  2. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,213
    Likes Received:
    1,085
    Recovering off a massive sell off yesterday
     
  3. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,213
    Likes Received:
    1,085
    BERKELEY, CA--(Marketwired - September 04, 2016) - Dynavax Technologies Corporation (DVAX) announced today that the U.S. Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research has cancelled the scheduled November 16, 2016, Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting to review the Biologics License Application (BLA) for HEPLISAV-B™ [Hepatitis B Vaccine, Recombinant (Adjuvanted)].
     
  4. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,213
    Likes Received:
    1,085
    Nice bounce off support levels, +19% today
     
  5. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,213
    Likes Received:
    1,085
    DVAX smacked down to 3.35, -71%

    Dynavax's stock plunges after disappointing FDA response to Hep-B treatment
     
  6. LloydWCoutee

    LloydWCoutee Active Member

    Joined:
    May 4, 2016
    Messages:
    720
    Likes Received:
    57
    reconsolidating here, watching for a $4.00 hold for more upside
     
  7. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,213
    Likes Received:
    1,085
    Now that the morning rush is done, lets see if it gets the follow through.
     
  8. anotherdevilsadvocate

    anotherdevilsadvocate Well-Known Member

    Joined:
    Apr 3, 2016
    Messages:
    1,784
    Likes Received:
    505
    http://www.marketwatch.com/story/dy...ng-fda-response-to-hep-b-treatment-2016-11-14
    Not a complete rejection, and the company's CEO thinks they can still get approval. And they're looking for a necessary buyout.
     
  9. Danny T

    Danny T Member

    Joined:
    Nov 9, 2016
    Messages:
    39
    Likes Received:
    7
    Grabbed some Dec $5 calls.
     
  10. Tiptopptrader

    Tiptopptrader Well-Known Member

    Joined:
    Mar 31, 2016
    Messages:
    5,035
    Likes Received:
    1,141
    DVAX plunges after disappointing FDA response to Hep-B treatment

    upload_2016-11-14_7-28-4.png
     
  11. Danny T

    Danny T Member

    Joined:
    Nov 9, 2016
    Messages:
    39
    Likes Received:
    7
    Getting closer to hod
     
  12. Gambit

    Gambit Active Member

    Joined:
    Oct 16, 2016
    Messages:
    701
    Likes Received:
    59
    $DVAX FDA has committed crime in the name of science to help big pharma, make drug expensive for years!
     
  13. fireopal

    fireopal Well-Known Member

    Joined:
    Apr 18, 2016
    Messages:
    1,662
    Likes Received:
    339
    PDUFA due 7/28. ER due first week of August
     
    #13 fireopal, Jul 23, 2017
    Last edited: Jul 23, 2017
  14. MiguelHammond10

    Joined:
    Jun 12, 2017
    Messages:
    74
    Likes Received:
    5
    poise to double on positive news. If Hep-B gets approved, could see $40 a share.
     
    fireopal likes this.
  15. fireopal

    fireopal Well-Known Member

    Joined:
    Apr 18, 2016
    Messages:
    1,662
    Likes Received:
    339
    ^^ best be good or it will be 3 strikes you're out!
     
  16. fireopal

    fireopal Well-Known Member

    Joined:
    Apr 18, 2016
    Messages:
    1,662
    Likes Received:
    339
    half out - swinging rest.
     
  17. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    5,213
    Likes Received:
    1,085
    Lots of active traders in here today
     
  18. fireopal

    fireopal Well-Known Member

    Joined:
    Apr 18, 2016
    Messages:
    1,662
    Likes Received:
    339
  19. fireopal

    fireopal Well-Known Member

    Joined:
    Apr 18, 2016
    Messages:
    1,662
    Likes Received:
    339
    It's a go >> 11 yes - 3 abstain - 1 no
     
  20. Gambit

    Gambit Active Member

    Joined:
    Oct 16, 2016
    Messages:
    701
    Likes Received:
    59
    DVAX selling is a great chance to buy cheaper! Remember FDA has 6 months after Ad-com decision. I wondered why PDUFA was within 2 weeks
     

Share This Page